CEMPRA PHARMACEUTICALS, INC.

Company number 322754
Download free PDF

No sign-up or report credits required

Get a detailed company report

Management and founders
Contact information
Risk factors
Registry checks
Court cases
History of changes to management, names, and addresses
Affiliated individuals and companies
By clicking the button, you agree to the terms of use and privacy policy.

Data updated: 06.10.2026

Contacts13

Phone

+░░░ ░░░ ░░░ ░░░

Email

░░░@░░░.░░

Website

░░░.░░░.░░░

Social networks

Registered agent & officers

Secretary of State Filings

Permits

Licenses

UCC Liens

Watchlist

Address

Country

United States

Region

NS

House number and street

Bldg. 2 Quadrangle, 6320 Quadrangle Dr., 3rd Floor, Shapel Hill, Ns, 27517, United States

Locality

NS

About INC «CEMPRA PHARMACEUTICALS»

CEMPRA PHARMACEUTICALS, INC. was registered on 15.09.2016.

corporation «CEMPRA PHARMACEUTICALS»: registration details and status

The company has the status “Inactive”; dissolution date — 17.05.2017. Registered address — Bldg. 2 Quadrangle, 6320 Quadrangle Dr., 3rd Floor, Shapel Hill, Ns, 27517, United States, region — NS, United States of America.

Management of INC «CEMPRA PHARMACEUTICALS»

Officers of INC «CEMPRA PHARMACEUTICALS»: Garheng Kong, M.d., Ph.d., M.b.a, Michael R. Doughtery, Richard Kent, M.d, David Moore, Dov A. Goldstein, M.d, David N. Gill, John H. Son Johnson, P. Sherrill Neff, Mark Hahn, David Zaccardelli, Pharm D, Incorporating Services, Ltd. Previously, INC «CEMPRA PHARMACEUTICALS» was headed by Mark Hahn.

Verification of INC «CEMPRA PHARMACEUTICALS» in official registries in the United States

Phone numbers, e-mail addresses, websites (13 contacts), and the list of officers of INC «CEMPRA PHARMACEUTICALS» are available in the full Statsnet report. Registration details, management, and status of INC «CEMPRA PHARMACEUTICALS» — based on official registry data in the United States in the Statsnet report. You can find any company by registration number or name via Statsnet search.

Frequently asked questions